Navigation Links
Hand Washing with 4% CHG Antiseptic Kills Flu Viruses
Date:6/24/2009

Hibiclens is an antimicrobial/antiseptic cleanser that kills germs on contact and bonds with the skin to keep killing microorganisms for up to six hours without leaving a residue. The same cleanser combined with alcohol is available in convenient Hibistat(R) towelettes. Both are available at drug stores and pharmacies in the first aid section. For more information about Hibiclens, Hibistat or CHG, visit www.hibigeebies.com.

About Molnlycke Health Care US, LLC

Molnlycke Health Care US, LLC, consists of two divisions - Surgical and Wound Care. Focusing on prevention of surgically-related infections for both patients and healthcare workers, the Surgical Division (formerly Regent Medical Americas, LLC) encompasses the world's leading manufacturer and supplier of powder-free surgical gloves (Biogel(R) surgical gloves); the number one supplier (by value) of skin cleanser (Hibiclens(R) and Hibistat(R) antiseptics); and BARRIER(R) protective clothing. A leader in trauma and pain management, the Wound Care Division's market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment.


'/>"/>
SOURCE Molnlycke Health Care
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Gene Found Activated in 70% of Prostate Cancer Cases, George Washington University Medical Center Scientists Report
2. Anpath Group, Inc. Advances Relationship With the Washington Metropolitan Area Transit Authority (Metro)
3. Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques
4. Resurgent Health and Medical Announces That Childrens Hospitals and Clinics of Minnesota has Ordered 25 CleanTech Automated Handwashing Systems
5. MedNet Solutions to Sponsor and Exhibit at the 2008 Advanced Medical Technology Association Conference in Washington, D.C.
6. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
7. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
8. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
9. DuPont Provides Technology for Washington Hospital Centers Emergency Department
10. Top Washington Health Officials to Honor Framingham Heart Study Participants
11. Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro)
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Momentum Women(TM) Honors Patricia Scheller of Prescient Medical for Commitment to Promoting Cardiovascular Disease Awareness 2Health News:Leveraging the Third Amendment Ruling the Risk Management Process: Frost & Sullivan's Assessment of Regulations for Medical Imaging Equipment in Europe 2Health News:Leveraging the Third Amendment Ruling the Risk Management Process: Frost & Sullivan's Assessment of Regulations for Medical Imaging Equipment in Europe 3Health News:Texas A&M Health Science Center College of Medicine Selects one45 Software's Healthcare Education Suite 2Health News:Texas A&M Health Science Center College of Medicine Selects one45 Software's Healthcare Education Suite 3Health News:Texas A&M Health Science Center College of Medicine Selects one45 Software's Healthcare Education Suite 4Health News:West-Com and Sonitor Present Joint Nurse Call and RTLS Solution 2Health News:West-Com and Sonitor Present Joint Nurse Call and RTLS Solution 3Health News:Ownership of electronic health information must be addressed, article says 2Health News:Ownership of electronic health information must be addressed, article says 3